Approval for the addition of the antibiotic trimethoprim/sulfamethoxazole at concentrations of 2/38, 8/152, 16/304 and 32/608 micrograms/ml to the vitek(r) 2 s. pneumoniae susceptibility test system. the device as modified, will be marketed under the trade name vitek(r) 2 s. pneumoniae susceptibility test cards for use in the vitek(r) 2 system and is indicated for use for the susceptibility testing of streptococcus pneumoniae to trimethoprim/sulfamethoxazole in the range of <=0.5/9.5 to >=16/304